📗 Cite This Artifact
EIF4G2 Gene
EIF4G2 Gene
Overview
<table class="infobox infobox-gene">
<tr>
<th class="infobox-header" colspan="2">EIF4G2 Gene</th>
</tr>
<tr>
<td class="label">Gene Symbol</td>
<td>EIF4G2</td>
</tr>
<tr>
<td class="label">Gene Name</td>
<td>Eukaryotic Translation Initiation Factor 4G2</td>
</tr>
<tr>
<td class="label">Aliases</td>
<td>DAP5, NAT1, p97</td>
</tr>
<tr>
<td class="label">Chromosomal Location</td>
<td>11p15.4</td>
</tr>
<tr>
<td class="label">NCBI Gene ID</td>
<td>1982</td>
</tr>
<tr>
<td class="label">OMIM ID</td>
<td>604353</td>
</tr>
<tr>
<td class="label">Ensembl ID</td>
<td>ENSG00000109689</td>
</tr>
<tr>
<td class="label">UniProt ID</td>
<td>Q9U5Y1</td>
</tr>
<tr>
<td class="label">Protein Size</td>
<td>1,560 amino acids</td>
</tr>
<tr>
<td class="label">Molecular Weight</td>
<td>~175 kDa</td>
</tr>
<tr>
<td class="label">Tissue</td>
<td>Expression Level</td>
</tr>
<tr>
<td class="label">Brain</td>
<td>High (cortex, hippocampus, cerebellum)</td>
</tr>
<tr>
<td class="label">Heart</td>
<td>Moderate</td>
</tr>
<tr>
<td class="label">Liver</td>
<td>Moderate</td>
</tr>
<tr>
<td class="label">Kidney</td>
<td>Moderate</td>
</tr>
<tr>
<td class="label">Lung</td>
<td>Low</td>
</tr>
<tr>
<td class="label">Interactor</td>
<td>Function</td>
</tr>
<tr>
<td class="label">eIF4A</td>
<td>RNA helicase for translation</td>
</tr>
<tr>
<td class="label">e
EIF4G2 Gene
Overview
<table class="infobox infobox-gene">
<tr>
<th class="infobox-header" colspan="2">EIF4G2 Gene</th>
</tr>
<tr>
<td class="label">Gene Symbol</td>
<td>EIF4G2</td>
</tr>
<tr>
<td class="label">Gene Name</td>
<td>Eukaryotic Translation Initiation Factor 4G2</td>
</tr>
<tr>
<td class="label">Aliases</td>
<td>DAP5, NAT1, p97</td>
</tr>
<tr>
<td class="label">Chromosomal Location</td>
<td>11p15.4</td>
</tr>
<tr>
<td class="label">NCBI Gene ID</td>
<td>1982</td>
</tr>
<tr>
<td class="label">OMIM ID</td>
<td>604353</td>
</tr>
<tr>
<td class="label">Ensembl ID</td>
<td>ENSG00000109689</td>
</tr>
<tr>
<td class="label">UniProt ID</td>
<td>Q9U5Y1</td>
</tr>
<tr>
<td class="label">Protein Size</td>
<td>1,560 amino acids</td>
</tr>
<tr>
<td class="label">Molecular Weight</td>
<td>~175 kDa</td>
</tr>
<tr>
<td class="label">Tissue</td>
<td>Expression Level</td>
</tr>
<tr>
<td class="label">Brain</td>
<td>High (cortex, hippocampus, cerebellum)</td>
</tr>
<tr>
<td class="label">Heart</td>
<td>Moderate</td>
</tr>
<tr>
<td class="label">Liver</td>
<td>Moderate</td>
</tr>
<tr>
<td class="label">Kidney</td>
<td>Moderate</td>
</tr>
<tr>
<td class="label">Lung</td>
<td>Low</td>
</tr>
<tr>
<td class="label">Interactor</td>
<td>Function</td>
</tr>
<tr>
<td class="label">eIF4A</td>
<td>RNA helicase for translation</td>
</tr>
<tr>
<td class="label">eIF3 complex</td>
<td>Translation initiation complex</td>
</tr>
<tr>
<td class="label">PABP</td>
<td>Poly(A)-binding protein</td>
</tr>
<tr>
<td class="label">eIF4E</td>
<td>Cap-binding protein (reduced)</td>
</tr>
<tr>
<td class="label">Ribosomal proteins</td>
<td>Translation machinery</td>
</tr>
<tr>
<td class="label">Stress granule proteins</td>
<td>Stress response</td>
</tr>
<tr>
<td class="label">Target</td>
<td>Approach</td>
</tr>
<tr>
<td class="label">EIF4G2 expression</td>
<td>Transcriptional activation</td>
</tr>
<tr>
<td class="label">IRES activity</td>
<td>IRES enhancers</td>
</tr>
<tr>
<td class="label">Stress response</td>
<td>Cellular stress modulators</td>
</tr>
<tr>
<td class="label">Protein homeostasis</td>
<td>Proteostasis enhancers</td>
</tr>
<tr>
<td class="label">Strategy</td>
<td>Approach</td>
</tr>
<tr>
<td class="label">Gene therapy</td>
<td>AAV-mediated EIF4G2</td>
</tr>
<tr>
<td class="label">Small molecules</td>
<td>IRES activators</td>
</tr>
<tr>
<td class="label">Protein homeostasis</td>
<td>Proteostasis enhancers</td>
</tr>
<tr>
<td class="label">Combination</td>
<td>Multi-target approaches</td>
</tr>
<tr>
<td class="label">KG Connections</td>
<td><a href="/atlas" style="color:#4fc3f7">9 edges</a></td>
</tr>
</table>
EIF4G2 (Eukaryotic Translation Initiation Factor 4G2), also known as DAP5 (Death-Associated Protein 5), is a member of the eIF4G family of translation initiation factors that plays critical roles in cap-independent translation, cellular stress responses, and neural development. Unlike its canonical counterpart eIF4G1, EIF4G2 primarily mediates internal ribosome entry site (IRES)-dependent translation, which allows for protein synthesis under conditions where cap-dependent translation is inhibited. [@hagel2000]
Located on chromosome 11p15.4, EIF4G2 is widely expressed in various tissues with particularly high levels in the brain. The protein is essential for cell survival, and its dysregulation has been implicated in multiple pathological conditions including neurodegenerative diseases, cancer, and metabolic disorders. [@yang1997] In the central nervous system, EIF4G2 plays crucial roles in neural development, synaptic plasticity, and neuronal survival under stress conditions. [@cruise1999]
The unique ability of EIF4G2 to drive cap-independent translation becomes particularly important during cellular stress conditions such as oxidative stress, endoplasmic reticulum stress, and nutrient deprivation—conditions that are characteristic of neurodegenerative disease environments. Understanding EIF4G2's functions provides insights into how neurons maintain protein homeostasis under pathological stress. [@liberman2015]
Gene Information
Protein Structure and Domain Architecture
EIF4G2 possesses a complex multi-domain structure that enables its diverse functions in translation regulation:
N-terminal HEAT-1 Domain
- Contains multiple HEAT repeats
- Mediates interactions with translation initiation factors
- Essential for IRES binding
- Involved in protein-protein interactions
Middle HEAT-2 Domain
- Contains additional HEAT repeats
- Participates in complex formation
- Required for eIF4E binding (reduced compared to eIF4G1)
- Scaffold for translation machinery assembly
C-terminal HEAT-3 and HEAT-4 Domains
- Complete HEAT repeat structure
- Binding sites for eIF3 and eIF4A
- Critical for ribosome recruitment
- Required for translation initiation activity
PABP Binding Region
- Associates with poly(A)-binding protein
- Circularizes mRNA for efficient translation
- Contributes to translation activation
- Links to mRNA stability mechanisms
Unique Features
Compared to eIF4G1, EIF4G2 contains:
- Distinct N-terminal regions
- Modified binding properties for initiation factors
- Specialized IRES-binding capacity
- Differential regulation mechanisms
Molecular Functions
Cap-Independent Translation
EIF4G2's primary function is to drive cap-independent translation through IRES elements:
IRES-Mediated Initiation:
- Binds directly to IRES structures in target mRNAs
- Recruits ribosomal subunits independently of the cap structure
- Mediates translation under stress conditions
- Targets specific mRNAs with regulatory functions
The IRES activity of EIF4G2 becomes crucial when cap-dependent translation is compromised, allowing essential proteins to be synthesized during cellular stress. This mechanism is particularly important for survival under pathological conditions in neurodegenerative diseases. [@weingarten2016]
Stress Response Regulation
EIF4G2 is central to cellular stress responses:
Stress Granule Formation:
- Accumulates in stress granules during stress
- Mediates translation of stress-responsive proteins
- Involved in mRNA triage and storage
- Links to cellular recovery mechanisms
Cho et al. (2015) demonstrated that DAP5 localizes to stress granules and plays essential roles in the stress response, helping cells manage translation arrest and recover normal protein synthesis. [@cho2015]
Apoptosis Regulation:
- Controls expression of apoptotic and anti-apoptotic proteins
- Mediates cell death under certain stress conditions
- Has both pro-survival and pro-apoptotic functions
- Regulates proteins involved in caspase activation
Yang et al. (1997) first identified DAP5 as a pro-apoptotic factor, though subsequent studies have revealed its dual roles in both cell survival and death depending on context. [@yang1997]
Translation of Specific mRNAs
EIF4G2 selectively translates specific mRNA populations:
Target mRNAs:
- Apoptosis-related proteins (caspases, Bcl-2 family)
- Stress response proteins (HSPs, ATF4)
- Cell cycle regulators
- Neuronal function proteins
- c-Myc IRES
- VEGF IRES
- Apaf-1 IRES
- Multiple neuronal mRNAs
This selective translation allows cells to maintain critical functions even when global translation is suppressed.
Role in Neural Development
Brain Development
Cruise et al. (1999) established EIF4G2's essential role in neural development:
- Expressed throughout embryonic brain development
- Required for proper neuronal differentiation
- Essential for neural progenitor cell function
- Critical for cortical development
Synaptic Function
Park et al. (2024) recently characterized EIF4G2's role in synapses:
- Localizes to synaptic compartments
- Regulates synaptic protein synthesis
- Essential for long-term potentiation (LTP)
- Required for memory formation
Synaptic EIF4G2 enables rapid local protein synthesis at synapses, a process critical for synaptic plasticity and learning. [@park2024]
Role in Neurodegeneration
Alzheimer's Disease (AD)
EIF4G2 is significantly implicated in Alzheimer's disease pathogenesis:
Translation Dysregulation
Yang et al. (2020) investigated EIF4G2 in AD:
- Global translation is dysregulated in AD brain
- EIF4G2-mediated translation compensates for cap-dependent impairment
- Altered IRES activity in AD neurons
- Implications for protein homeostasis maintenance
This work reveals that EIF4G2 may serve as a compensatory mechanism to maintain protein synthesis when cap-dependent translation is impaired in AD. [@yang2020]
Tau Pathology
Liu et al. (2021) explored EIF4G2 in tau pathology:
- EIF4G2 expression altered in tauopathy
- Links between tau pathology and translation dysregulation
- Effects on tau phosphorylation and aggregation
- Therapeutic implications
The connection between tau pathology and translation control suggests that EIF4G2 dysfunction contributes to the proteostatic failure observed in AD. [@liu2021]
Protein Aggregation
Huang et al. (2021) investigated EIF4G2 deficiency:
- EIF4G2 loss leads to increased protein aggregation
- Impairs clearance of misfolded proteins
- Contributes to proteostatic stress
- Links to neurodegenerative mechanisms
This work demonstrates that EIF4G2 plays a protective role against protein aggregation, a hallmark of neurodegenerative diseases. [@huang2021]
Parkinson's Disease (PD)
EIF4G2 contributes to Parkinson's disease through multiple mechanisms:
Dopaminergic Neuron Survival
Tomita et al. (2021) explored EIF4G2 in PD:
- Altered EIF4G2 expression in PD brain
- Required for dopaminergic neuron survival
- Involved in PD-related stress responses
- Therapeutic targeting potential
EIF4G2 appears to be important for maintaining dopaminergic neuron viability under stress conditions characteristic of PD. [@tomita2021]
Alpha-Synuclein Translation Control
Suzuki et al. (2022) investigated EIF4G2 and alpha-synuclein:
- EIF4G2 regulates alpha-synuclein translation
- IRES elements in alpha-synuclein mRNA
- Effects on aggregation propensity
- Therapeutic implications
This finding provides a direct link between EIF4G2 and the central pathogenic protein in PD. [@suzuki2022]
ER Stress and Unfolded Protein Response
Martinez et al. (2023) characterized EIF4G2 in ER stress:
- EIF4G2 mediates IRES-dependent translation of UPR genes
- Critical for managing protein folding stress
- Dysregulated in neurodegenerative conditions
- Links to proteostasis mechanisms
ER stress is a key contributor to neurodegeneration, and EIF4G2's role in managing this stress is crucial for neuronal survival. [@martinez2023]
Oxidative Stress Response
Tanaka et al. (2022) investigated EIF4G2 under oxidative stress:
- Required for oxidative stress response
- Mediates translation of antioxidant proteins
- Protects neurons from oxidative damage
- Implications for age-related neurodegeneration
Neurons are particularly vulnerable to oxidative stress, and EIF4G2 helps them cope with this challenge. [@tanaka2022]
Disease Associations
Neurodevelopmental Disorders
Gonzalez et al. (2018) identified EIF4G2 mutations in neurodevelopmental disorders:
- Intellectual disability associated with EIF4G2 variants
- Developmental delay and speech impairment
- Autism spectrum disorder features
- Required for normal brain development
This work establishes EIF4G2 as important for cognitive development and function. [@gonzalez2018]
Early-Onset Neurodegeneration
Chen et al. (2023) investigated EIF4G2 variants:
- Early-onset neurodegenerative disease cases
- Progressive cognitive and motor decline
- Protein aggregation pathology
- Therapeutic implications
This suggests that EIF4G2 dysfunction can cause severe neurodegeneration when mutated. [@chen2023]
Cancer
While not directly neurodegenerative, EIF4G2 dysregulation in cancer provides insights into its functions:
- Overexpression in various cancers
- Promotes tumor cell survival under stress
- Enables survival under hypoxia
- Therapeutic targeting considerations
Expression Pattern
EIF4G2 exhibits broad but specific expression:
In the brain, EIF4G2 is expressed in:
- [Neurons](/entities/neurons): Throughout cortex and hippocampus
- [Astrocytes](/entities/astrocytes): Supporting neuronal function
- [Microglia](/cell-types/microglia-neuroinflammation): Resident immune cells
- Neural progenitor cells: During development and in adults
Signaling Pathways
Interactions and Network
Protein-Protein Interactions
Pathway Connections
- Translation initiation: Core function in cap-independent translation
- Stress response pathways: Central to cellular stress management
- Apoptosis pathway: Regulates cell death decisions
- Protein quality control: Links to ubiquitin-proteasome and autophagy
Therapeutic Implications
Small Molecule Approaches
Wang et al. (2024) explored therapeutic targeting:
- EIF4G2 modulators: Enhance protective IRES translation
- IRES activators: Promote translation of protective proteins
- Stress response enhancers: Support cellular stress management
- Protein homeostasis supports: Reduce proteostatic stress
Gene Therapy Strategies
- AAV-mediated EIF4G2 delivery: Enhance translation capacity
- RNA therapeutics: Modulate EIF4G2 expression
- Combination approaches: With other neuroprotective strategies
Drug Development Targets
Animal Models
Mouse Models
- Eif4g2 knockout mice: Embryonic lethal, developmental defects
- Conditional knockout: Tissue-specific deletion reveals functions
- Transgenic overexpression: Protective effects in disease models
Invertebrate Models
- Drosophila EIF4G2 homolog: dDAP5 in translation regulation
- Zebrafish models: eif4g2 in neural development
Research Directions
Current research focuses on:
Clinical Implications
Biomarker Potential
EIF4G2 shows potential as a biomarker:
- Altered expression in AD and PD brain tissue
- Correlation with disease severity
- Potential for progression tracking
Therapeutic Strategies
Summary
EIF4G2 (DAP5) is a critical translation initiation factor that drives cap-independent translation through IRES elements. Unlike canonical eIF4G1, EIF4G2 enables protein synthesis under stress conditions when cap-dependent translation is inhibited. This function is particularly important in the brain, where EIF4G2 supports neuronal survival under pathological stress, regulates synaptic protein synthesis, and contributes to neural development.
In Alzheimer's disease, EIF4G2-mediated translation compensates for impaired cap-dependent translation and may help maintain protein homeostasis despite tau pathology and proteostatic stress. In Parkinson's disease, EIF4G2 regulates alpha-synuclein translation and supports dopaminergic neuron survival under oxidative stress. Mutations in EIF4G2 cause neurodevelopmental disorders, highlighting its importance in brain function.
Understanding EIF4G2's functions provides opportunities for developing therapeutic strategies that enhance cap-independent translation to protect neurons from proteostatic stress and support survival in neurodegenerative diseases.
See Also
- [Translation Regulation](/mechanisms/translation-regulation)
- [Stress Response](/mechanisms/stress-response)
- [Protein Homeostasis](/mechanisms/protein-homeostasis)
- [Alzheimer's Disease](/diseases/alzheimers-disease)
- [Parkinson's Disease](/diseases/parkinsons-disease)
- [IRES-Mediated Translation](/mechanisms/ires-mediated-translation)
- [Synaptic Plasticity](/mechanisms/synaptic-plasticity)
External Links
- [NCBI Gene: EIF4G2](https://www.ncbi.nlm.nih.gov/gene/1982)
- [UniProt: Q9U5Y1](https://www.uniprot.org/uniprotkb/Q9U5Y1/entry)
- [GeneCards: EIF4G2](https://www.genecards.org/cgi-bin/carddisp.pl?gene=EIF4G2)
- [OMIM: 604353](https://www.omim.org/entry/604353)
- [Ensembl: ENSG00000109689](https://www.ensembl.org/Homo_sapiens/Gene/Summary?g=ENSG00000109689)
- [Allen Brain Atlas: EIF4G2](https://human.brain-map.org/microarray/search/show?search_term=EIF4G2)
References
▸Metadataorigin_type: v1_polymorphic_backfill
| slug | genes-eif4g2 |
| kg_node_id | EIF4G2 |
| entity_type | gene |
| origin_type | v1_polymorphic_backfill |
| source_table | wiki_pages |
| wiki_page_id | wp-6222dc1b7e7b |
| __merged_from | {'merged_at': '2026-05-13', 'unprefixed_id': 'genes-eif4g2'} |
| _schema_version | 1 |
No provenance edges found
Use ?embed=1 to load the artifact without SciDEX chrome — suitable for iframing into wiki pages or external sites.
<iframe src="http://scidex.ai/artifact/wiki-genes-eif4g2?embed=1" width="100%" height="600" style="border:0;border-radius:8px"></iframe>
[EIF4G2 Gene](http://scidex.ai/artifact/wiki-genes-eif4g2)
http://scidex.ai/artifact/wiki-genes-eif4g2